Prat A - Search Results

1

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer.

Cejalvo JM, Pascual T, Fernández-Martínez A, Brasó-Maristany F, Gomis RR, Perou CM, Muñoz M, Prat A. Cejalvo JM, et al. Among authors: prat a. Cancer Treat Rev. 2018 Jun;67:63-70. doi: 10.1016/j.ctrv.2018.04.015. Epub 2018 May 7. Cancer Treat Rev. 2018. PMID: 29763779 Free article. Review.

2

The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Prat A, Baselga J. Prat A, et al. Nat Clin Pract Oncol. 2008 Sep;5(9):531-42. doi: 10.1038/ncponc1179. Epub 2008 Jul 8. Nat Clin Pract Oncol. 2008. PMID: 18607391 Review.

3

Mammary development meets cancer genomics.

Prat A, Perou CM. Prat A, et al. Nat Med. 2009 Aug;15(8):842-4. doi: 10.1038/nm0809-842. Nat Med. 2009. PMID: 19661985 No abstract available.

4

WITHDRAWN: Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2010 Apr 14. doi: 10.1016/j.molonc.2010.04.003. Online ahead of print. Mol Oncol. 2010. PMID: 20447881 Free article. No abstract available.

5

Clinical implementation of the intrinsic subtypes of breast cancer.

Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS. Perou CM, et al. Among authors: prat a. Lancet Oncol. 2010 Aug;11(8):718-9; author reply 720-1. doi: 10.1016/S1470-2045(10)70176-5. Lancet Oncol. 2010. PMID: 20688274 No abstract available.

6

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Prat A, et al. Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2. Breast Cancer Res. 2010. PMID: 20813035 Free PMC article.

7

Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2011 Feb;5(1):5-23. doi: 10.1016/j.molonc.2010.11.003. Epub 2010 Nov 24. Mol Oncol. 2011. PMID: 21147047 Free PMC article. Review.

8

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.

Fan C, Prat A, Parker JS, Liu Y, Carey LA, Troester MA, Perou CM. Fan C, et al. Among authors: prat a. BMC Med Genomics. 2011 Jan 9;4:3. doi: 10.1186/1755-8794-4-3. BMC Med Genomics. 2011. PMID: 21214954 Free PMC article.

9

MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells.

Abell AN, Jordan NV, Huang W, Prat A, Midland AA, Johnson NL, Granger DA, Mieczkowski PA, Perou CM, Gomez SM, Li L, Johnson GL. Abell AN, et al. Among authors: prat a. Cell Stem Cell. 2011 May 6;8(5):525-37. doi: 10.1016/j.stem.2011.03.008. Cell Stem Cell. 2011. PMID: 21549327 Free PMC article.

10

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.

Harrell JC, Prat A, Parker JS, Fan C, He X, Carey L, Anders C, Ewend M, Perou CM. Harrell JC, et al. Among authors: prat a. Breast Cancer Res Treat. 2012 Apr;132(2):523-35. doi: 10.1007/s10549-011-1619-7. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

944 results

Search Page

Filters